This topic contains a solution. Click here to go to the answer

Author Question: A patient with severe glucocorticoid-induced osteoporosis will start therapy with teriparatide ... (Read 18 times)

Alainaaa8

  • Hero Member
  • *****
  • Posts: 576
A patient with severe glucocorticoid-induced osteoporosis will start therapy with teriparatide (Forteo). What will the nurse expect to administer?
 
  a. 20 mcg once daily subQ
  b. 20 mcg twice daily subQ
  c. 10 mcg once daily subQ
  d. 10 mcg twice daily subQ

Question 2

A patient reports experiencing weakness, fatigue, nausea, vomiting, constipation, and nocturia. A dipstick urinalysis shows a positive result for protein. When questioned, the patient reports taking vitamin D and calcium supplements.
 
  The nurse will counsel the patient to:
  a. reduce the amount of vitamin D and stop taking the calcium.
  b. discuss taking calcitonin-salmon (Fortical) with the provider.
  c. stop both supplements and discuss the use of a diuretic with the provider.
  d. stop taking vitamin D, reduce the amount of calcium, and increase the fluid intake.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jaygar71

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

ANS: A
The dose of teriparatide for all indications is 20 mcg once daily subQ.

Answer to Question 2

ANS: D
Vitamin D toxicity can occur, and early responses include the symptoms described. Patients should be counseled to stop taking vitamin D, reduce their calcium intake, and increase their fluid intake. It is not correct to reduce the vitamin D intake and the calcium intake. Calcitonin-salmon is not indicated. A diuretic is indicated when hypercalciuria is severe.




Alainaaa8

  • Member
  • Posts: 576
Reply 2 on: Jul 23, 2018
Wow, this really help


xiaomengxian

  • Member
  • Posts: 311
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

For a complete list of videos, visit our video library